Diet and lifestyle factors modify immune/inflammation response genes to alter breast cancer risk and prognosis: the Breast Cancer Health Disparities Study
- PMID: 25332681
- PMCID: PMC4201121
- DOI: 10.1016/j.mrfmmm.2014.08.009
Diet and lifestyle factors modify immune/inflammation response genes to alter breast cancer risk and prognosis: the Breast Cancer Health Disparities Study
Abstract
Tumor necrosis factor-α (TNF) and toll-like receptors (TLR) are important mediators of inflammation. We examined 10 of these genes with respect to breast cancer risk and mortality in a genetically admixed population of Hispanic/Native American (NA) (2111 cases, 2597 controls) and non-Hispanic white (NHW) (1481 cases, 1585 controls) women. Additionally, we explored if diet and lifestyle factors modified associations with these genes. Overall, these genes (collectively) were associated with breast cancer risk among women with >70% NA ancestry (P(ARTP) = 0.0008), with TLR1 rs7696175 being the primary risk contributor (OR 1.77, 95% CI 1.25, 2.51). Overall, TLR1 rs7696175 (HR 1.40, 95% CI 1.03, 1.91; P(adj) = 0.032), TLR4 rs5030728 (HR 1.96, 95% CI 1.30, 2.95; P(adj) = 0.014), and TNFRSF1A rs4149578 (HR 2.71, 95% CI 1.28, 5.76; P(adj) = 0.029) were associated with increased breast cancer mortality. We observed several statistically significant interactions after adjustment for multiple comparisons, including interactions between our dietary oxidative balance score and CD40LG and TNFSF1A; between cigarette smoking and TLR1, TLR4, and TNF; between body mass index (BMI) among pre-menopausal women and TRAF2; and between regular use of aspirin/non-steroidal anti-inflammatory drugs and TLR3 and TRA2. In conclusion, our findings support a contributing role of certain TNF-α and TLR genes in both breast cancer risk and survival, particularly among women with higher NA ancestry. Diet and lifestyle factors appear to be important mediators of the breast cancer risk associated with these genes.
Conflict of interest statement
Conflict of Interest Statement.
The authors have no conflict of interest to report.
References
-
- Gao Z, Zuberi A, Quon MJ, Dong Z, Ye J. Aspirin Inhibits Serine Phosphorylation of Insulin Receptor Substrate 1 in Tumor Necrosis Factor-treated Cells through Targeting Multiple Serine Kinases. J Biol Chem. 2003;278:24944–24950. - PubMed
-
- Xu H, Hotamisligil GS. Signaling pathways utilized by tumor necrosis factor receptor 1 in adipocytes to suppress differentiation. FEBS Lett. 2001;506:97–102. - PubMed
-
- Hotamisligil GS. The role of TNFalpha and TNF receptors in obesity and insulin resistance. J Intern Med. 1999;245:621–625. - PubMed
-
- Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, et al. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science. 1996;271:665–668. - PubMed
-
- Hofmann C, Lorenz K, Braithwaite SS, Colca JR, Palazuk BJ, et al. Altered gene expression for tumor necrosis factor-alpha and its receptors during drug and dietary modulation of insulin resistance. Endocrinology. 1994;134:264–270. - PubMed
Publication types
MeSH terms
Grants and funding
- CA77305/CA/NCI NIH HHS/United States
- CA078682/CA/NCI NIH HHS/United States
- R01 CA078552/CA/NCI NIH HHS/United States
- R01 CA078762/CA/NCI NIH HHS/United States
- 1U58 DP000807-01/DP/NCCDPHP CDC HHS/United States
- R01 CA140002/CA/NCI NIH HHS/United States
- R01 CA063446/CA/NCI NIH HHS/United States
- R03 CA121875/CA/NCI NIH HHS/United States
- CA078552/CA/NCI NIH HHS/United States
- N01-PC-67000/PC/NCI NIH HHS/United States
- CA078802/CA/NCI NIH HHS/United States
- U58 DP000807/DP/NCCDPHP CDC HHS/United States
- R01 CA078802/CA/NCI NIH HHS/United States
- R01 CA078682/CA/NCI NIH HHS/United States
- CA14002/CA/NCI NIH HHS/United States
- CA078762/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
